Key Market Indicator:
F&G: 25
25.065,70 NASDAQ · 47.321,00 DOW · 6.739,65 S&P · 4.091,18 Gold · 63,89 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
16.09.2025
ISIN: US4169061052
Harvard Bioscience Inc
HBIO
LISTED
NASDAQ
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
Article
News Preview
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
Article
News Preview
SAN CARLOS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea or Biomea Fusion) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of preclinical data from its investigational menin inhibitor icovamenib in combination with semaglutide in a T2D animal model. The oral pres...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
Article
News Preview
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. (“Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and consumer packaged goods company, together with Oregon Athletics, are excited to announce the relea...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
16.09.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Article
News Preview
WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
16.09.2025
ISIN: US88032L6056
Tenax Therapeutics, Inc.
TENX
LISTED
NASDAQ
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Article
News Preview
Provides Patent Protection in Europe Through at Least December 2040...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US9250501064
Verona Pharma plc
VRNA
LISTED
NASDAQ
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
Article
News Preview
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
Article
News Preview
Bagsværd, Denmark, 16 September 2025 – Novo Nordisk today presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes (EASD) congress 2025 from 15–19 September in Vienna, Austria. This sub-analysis evaluated the efficacy and safety of once-weekly cagrilintide 2.4 mg monotherapy, plus life...
Themefolio
Profiler
Peergroup
© Newsfile
16.09.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Appoints Dr. Amie Phinney as Director
Article
News Preview
Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the appointment of Dr. Amie Phinney, PhD, MBA to its Board of Directors, effective immediately.D...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
Article
News Preview
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing efficiently, Cohort 4 open for enrollment SEATTLE, WA / ACCESS Newswire / September 16, 2025 / Aptevo Therapeutics ("Aptevo" or "the Company") (NASDAQ:APVO), a cli...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement
Article
News Preview
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™ pre-workout:50mg caffeine for energy and focus.Boosts performance potential.Stick packs:Convenient, no water needed.Precise caffeine doseGlo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
Article
News Preview
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutic...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company AnaCardio completes patient recruitment in phase 2a study of its drug candidate AC01
Article
News Preview
STOCKHOLM, SWEDEN September 16, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed enrollment in the phase 2a part of its clinical study GOAL-HF1. The ongoing study evaluates AnaCardio’s drug candidate AC01 in patients with heart failure and reduced ejection fraction, with res...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
Article
News Preview
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf Mailand, Italien – 16. September 2025, 07:00 Uhr MESZ – Newron Pharmaceuticals S.p.A. („Newron”, ISIN: IT0004147952, SIX: NWRN, XETRA: NP5) gibt heute die finanziellen und operativen Höhepunkte des zum 30. Juni 2025 endenden Halbjahres bekannt......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron presents H1 2025 results and provides business update
Article
News Preview
Newron presents H1 2025 results and provides business update  Milan, Italy, September 16, 2025, 07:00 am CEST – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its fina......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf
Article
News Preview
Newron veröffentlicht die Ergebnisse des ersten Halbjahres 2025 und gibt ein Update zum Geschäftsverlauf Mailand, Italien – 16. September 2025, 07:00 Uhr MESZ – Newron Pharmaceuticals S.p.A. („Newron”, SIX: NWRN, XETRA: NP5), ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung neuartiger Therapien für Patienten mit Erkrankungen des ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
Article
News Preview
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / September 16, 2025 / CBD Life Sciences Inc. (OTC:CBDL), t...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000OCC6
Orthocell Limited
OCC
LISTED
ASX
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
Article
News Preview
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia for use in nerve-spa...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000OCC6
Orthocell Limited
OCC
LISTED
ASX
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
Article
News Preview
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia for use in nerve-spa...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Article
News Preview
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groupsClinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) tod...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Did You Lose Money in LifeMD, Inc? If You Suffered Significant Financial Loss in LFMD Contact Robbins LLP for Information About Leading the LFMD Class Action Lawsuit
Article
News Preview
SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Did You Lose Money in Semler Scientific, Inc.? If You Suffered Significant Financial Loss in SMLR Contact Robbins LLP for Information About Leading the SMLR Class Action Lawsuit
Article
News Preview
SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets techn...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CH0011432447
Basilea Pharmaceutica AG Allschwil
BSLN
LISTED
SIX
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Article
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Akeso's Ligufalimab (CD47 mAb) Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia (AML)
Article
News Preview
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that its proprietary next-generation humanized IgG4 monoclonal antibody targeting CD47, ligufalimab (AK117), has been granted Orphan Drug Designation (ODD) by the U.S. FDA for the treatment of acute myeloid leukemia (AML). The Orphan Drug Designation is a program esta...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KYG4818G1010
Innovent Biologics Inc
1801
LISTED
HKSE
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
Article
News Preview
SAN FRANCISCO and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, ann...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference
Article
News Preview
SECAUCUS, N.J., Sept. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Jefferies Healthcar...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting f...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ --  Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR). If you c...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US10920G1004
Bright Green Corp
BGXX
LISTED
NASDAQ
Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Article
News Preview
Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
Article
News Preview
GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collective...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on September 15, 2025, a non-qualified stock option to purchase an aggregate of 440,000 shares of its common stock to Personalis’ new Senior Vice President, Chief Information Offi...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US89157D1054
Tourmaline Bio Inc
TALS
LISTED
NASDAQ
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Tourmaline Bio, Inc. (NASDAQ: TRML)
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA0342231077
Andlauer Healthcare Group Inc
AND
LISTED
TSX
Andlauer Healthcare Announces Third Quarter Dividend
Article
News Preview
TORONTO, Sept. 15, 2025 /CNW/ - Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's third quarter shareholder dividend (encompassing the period from July 1, 2025 to September 30, 2025) in the amount of $0.12 per subordinate voting share and multiple voting share. Payment will be made on October 15, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Apria and Byram Join New Optum Preferred DME Network
Article
News Preview
Apria Healthcare, LLC and Byram Healthcare Centers, Inc., national leaders in home-based care and part of the Owens & Minor (NYSE: OMI) family, today announced a new national provider agreement with Optum Health – a patient-centered care organization that helps deliver better experiences for patients and providers, improve health outcomes and...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah reicht Klage wegen Patentverletzung gegen Inspire Medical Systems, Inc. ein
Article
News Preview
Nyxoah reicht Klage wegen Patentverletzung gegen Inspire Medical Systems, Inc. ein Mont-Saint-Guibert, Belgien – 15. September 2025, 22:40 Uhr MESZ – Nyxoah SA (Euronext Brüssel/Nasdaq: NYXH) und Nyxoah, Inc. (zusammen „Nyxoah” oder das „Unternehmen”), ein Medizintechnikunternehmen, das innovative Technologien zur Behandlung der obstruktiven Schla......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Article
News Preview
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgium – September 15, 2025, 10:40pm CET / 4:40pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc. (collectively, “Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstruc......
Themefolio
Profiler
Peergroup
© Newsfile
15.09.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
Article
News Preview
Montreal, Quebec--(Newsfile Corp. - September 15, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the closing of its previously announced non-brokered private placement of debenture units (...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
UnitedHealth Group Announces Earnings Release Date
Article
News Preview
UnitedHealth Group (NYSE: UNH) will release its third quarter 2025 financial results on Tuesday, October 28, 2025, before the market opens, and will host a teleconference at 8:00 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com)....
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Alex M. Azar II Joins Guardant Health Board of Directors
Article
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Alex M. Azar II to its board of directors, effective immediately. As the 24th Secretary of the U.S. Department of Health and Human Services (HHS), Secretary Azar had oversight and management of agencies critical to all Americans’ health car...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US74765K1051
Quantum-Si Inc
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 17,033 restricted stock units (“RSUs”) to new employees under the Company’s previ...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being
Article
News Preview
Bagsværd, Denmark, 16 September 2025 – Novo Nordisk today announced results from the US-based INFORM survey of people taking semaglutide for weight management (Wegovy®), at the European Association for the Study of Diabetes (EASD) 2025, Vienna, Austria. The INFORM survey revealed that individuals experienced a substantial drop in food noise after s...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA45783P5085
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Article
News Preview
HERZLIYA, Israel and CALGARY, Alberta, Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr., MD, MBA, at the...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA45783P5085
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Article
News Preview
HERZLIYA, Israel and CALGARY, Alberta, Sept. 15, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr., MD, MBA, at the PAINWee...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Article
News Preview
SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that it has closed its previously announced underwritten public offering of 17,250,000 shares of its common stock...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen® Announces CFO Transition Plan
Article
News Preview
Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that David Naemura, Chief Financial Officer and Chief Operating Officer, has communicated his intention to depart the Company. Mr. Naemura will continue to serve in his existing roles until his departure, which is expected to occur after the Company’...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
RISE Dispensaries to Launch Adult-Use Cannabis Sales at RISE Minnesota Locations on September 17
Article
News Preview
Adult-Use Cannabis Sales to Begin at 9:00 a.m. on September 17 at RISE Dispensaries in Brooklyn Park, Eagan, Mankato, New Hope, and Willmar Adult-Use Cannabis Sales to Begin at 9:00 a.m. on September 17 at RISE Dispensaries in Brooklyn Park, Eagan, Mankato, New Hope, and Willmar...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US19188J4094
Cocrystal Pharma Inc
COCP
LISTED
NASDAQ
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Article
News Preview
$4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Article
News Preview
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc....
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties
Article
News Preview
PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Lantheus Holdings, Inc. (LNTH)
Article
News Preview
RADNOR, Pa., Sept. 15, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025,...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Article
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or “the Company”) (NASDAQ: AGIO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or fail...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Savara Inc. (SVRA) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025,, inclusive (the “Class Period”). Savara investors have until November 7, 2025 to file a lead plaintiff motion. IF YOU...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). Lantheus investors have until November 10, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR
Article
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors....
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health Unveils State-of-the-Art Consumer Health Logistics Center
Article
News Preview
DUBLIN, Ohio, Sept. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport, Ohio. Purpose-built as a centralized replenishment hub, this facility serves as a vital link in the company's supply chain, efficiently distributing over-...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US9139031002
Universal Health Services Inc
UHS
LISTED
NYSE
Universal Health Services, Inc. Appoints Darren Lehrich as Vice President of Investor Relations
Article
News Preview
KING OF PRUSSIA, Pa., Sept. 15, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS), one of the largest and most respected providers of hospital and healthcare services, announced today that Darren Lehrich has joined as Vice President of Investor Relations. Lehrich reports to CFO Steve Filton in the newly established investor relatio...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). Lantheus investors have until November 10, 2025 to file a lead plainti...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Deadline Soon: Neogen Corporation (NEOG) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Article
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 16, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 14.11.2025, Calendar Week 46, 318th day of the year, 47 days remaining until EoY.